Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 14NOVARTIS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ALPELISIB

US Patent Number : 8227462

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212526

Patent Use Code : U-3809

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-04-29

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ALPELISIB

US Patent Number : 8227462

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212526

Patent Use Code : U-3809

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-04-29

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ALPELISIB

US Patent Number : 8227462

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212526

Patent Use Code : U-3809

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-04-29

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ALPELISIB

US Patent Number : 8476268

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 218466

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-09-10

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ALPELISIB

US Patent Number : 8476268

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212526

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-09-10

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ALPELISIB

US Patent Number : 8476268

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212526

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-09-10

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ALPELISIB

US Patent Number : 8476268

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 215039

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-09-10

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ALPELISIB

US Patent Number : 8227462

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 215039

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-04-29

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ALPELISIB

US Patent Number : 8476268

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 215039

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-09-10

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ALPELISIB

US Patent Number : 8227462

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 215039

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-04-29

blank